AXL and pulmonary fibrosis: AXL has been implicated in pneumonia, cytokine storm, systemic inflammation, and lung fibrosis, and thus repurposing of AXL inhibitors would be anticipated to possibly exhibit a dual, clinically beneficial effect through preventing viral entry and reducing the related inflammatory response and cytokine storm.12, 14, 20